Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mangoceuticals (MGRX) EBT Margin (2023 - 2025)

Historic EBT Margin for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to 9043.49%.

  • Mangoceuticals' EBT Margin fell 75441100.0% to 9043.49% in Q3 2025 from the same period last year, while for Sep 2025 it was 4245.52%, marking a year-over-year decrease of 30102000.0%. This contributed to the annual value of 1413.8% for FY2024, which is 1544000.0% down from last year.
  • As of Q3 2025, Mangoceuticals' EBT Margin stood at 9043.49%, which was down 75441100.0% from 3221.61% recorded in Q2 2025.
  • Mangoceuticals' 5-year EBT Margin high stood at 733.99% for Q3 2023, and its period low was 9043.49% during Q3 2025.
  • In the last 3 years, Mangoceuticals' EBT Margin had a median value of 1617.16% in 2023 and averaged 2596.31%.
  • In the last 5 years, Mangoceuticals' EBT Margin soared by 14366600bps in 2024 and then crashed by -75441100bps in 2025.
  • Mangoceuticals' EBT Margin (Quarter) stood at 1050.87% in 2023, then tumbled by -76bps to 1851.45% in 2024, then plummeted by -388bps to 9043.49% in 2025.
  • Its last three reported values are 9043.49% in Q3 2025, 3221.61% for Q2 2025, and 4427.47% during Q1 2025.